The Department of Health and Human Services’ Office of Inspector General found that taxpayers fund billions of dollars in overpayments to Medicare Advantage companies each year based on unsupported diagnoses for enrollees. Twenty Medicare Advantage companies each had a share of payments from health risk assessments and HRA-linked chart reviews that exceeded their percentage of enrollees by more than 25%, the agency said in a report. Taken together, these 20 companies generated 80%, or $6B of $7.5B, of the estimated 2023 risk-adjusted payments from HRAs and HRA-linked chart reviews while covering only half of Medicare Advantage enrollees. One top Medicare Advantage company, UnitedHealth Group (UNH), “stood out from its peers, especially in its use of in-home HRAs and HRA-linked chart reviews to generate risk-adjusted payments,” according to the Office of Inspector General. Ohers involved include Alignment Healthcare (ALHC), Humana (HUM) and Cigna (CI), according to the agency.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on UNH:
- Medicare paid insurers approx $4.2B for home diagnoses, WSJ reports
- Is UnitedHealth Group Stock (NYSE:UNH) a Buy on the Dip?
- UnitedHealth price target lowered to $603 from $604 at Barclays
- Election 2024: Where To Put Your Money Ahead of the Vote
- UnitedHealth incentivized doctors to pile diagnoses onto MA patients, STAT says
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
